Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020)
Sarepta Therapeutics (SRPT) posted quarterly Change in Intangibles of $108.1 million for Q1 2020, down 13.54% quarter-over-quarter from $125.0 million in Q1 2017.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Change in Intangibles (2017 - 2020) Analysis & Trends
Sarepta Therapeutics' Change in Intangibles history runs 2 years deep, the most recent figure standing at $108.1 million for Q1 2020.
- In Q1 2020, Change in Intangibles changed N/A year-over-year to $108.1 million; the TTM figure through Dec 2020 stood at $108.1 million (changed N/A YoY), while the FY2023 annual figure was $102.0 million, changed N/A from the prior year.
- Change in Intangibles for Q1 2020 stood at $108.1 million, down from $125.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $125.0 million in Q1 2017, with the low at $108.1 million in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | - |